F&FFinancial Insights

Financial Metrics

BTSGU BrightSpring Health Services, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 2028378000.0 USD 10-Q 2024-05-02
Quarterly 2023-06-30 2166724000.0 +6.8% USD 10-Q 2024-08-02
Quarterly 2023-09-30 2256529000.0 +4.1% USD 10-Q 2024-11-01
Quarterly 2024-03-31 2285766000.0 +1.3% USD 10-Q 2025-05-02
Quarterly 2024-06-30 2438254000.0 +6.7% USD 10-Q 2025-08-01
Quarterly 2024-09-30 2601229000.0 +6.7% USD 10-Q 2025-10-28
Quarterly 2025-03-31 2878129000.0 +10.6% USD 10-Q 2025-05-02
Quarterly 2025-06-30 3147698000.0 +9.4% USD 10-Q 2025-08-01
Quarterly 2025-09-30 3334106000.0 +5.9% USD 10-Q 2025-10-28
Annual 2022-12-31 7720560000.0 USD 10-K 2025-03-06
Annual 2023-12-31 7691016000.0 -0.4% USD 10-K 2026-02-27
Annual 2024-12-31 10072214000.0 +31.0% USD 10-K 2026-02-27
Annual 2025-12-31 12910564000.0 +28.2% USD 10-K 2026-02-27

Gross Profit

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 334713000.0 USD 10-Q 2024-05-02
Quarterly 2023-06-30 372070000.0 +11.2% USD 10-Q 2024-08-02
Quarterly 2023-09-30 358296000.0 -3.7% USD 10-Q 2024-11-01
Quarterly 2024-03-31 292491000.0 -18.4% USD 10-Q 2025-05-02
Quarterly 2024-06-30 312176000.0 +6.7% USD 10-Q 2025-08-01
Quarterly 2024-09-30 323092000.0 +3.5% USD 10-Q 2025-10-28
Quarterly 2025-03-31 338369000.0 +4.7% USD 10-Q 2025-05-02
Quarterly 2025-06-30 374852000.0 +10.8% USD 10-Q 2025-08-01
Quarterly 2025-09-30 392008000.0 +4.6% USD 10-Q 2025-10-28
Annual 2022-12-31 1354244000.0 USD 10-K 2025-03-06
Annual 2023-12-31 1138996000.0 -15.9% USD 10-K 2026-02-27
Annual 2024-12-31 1266427000.0 +11.2% USD 10-K 2026-02-27
Annual 2025-12-31 1517777000.0 +19.8% USD 10-K 2026-02-27

Operating Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 51555000.0 USD 10-Q 2024-05-02
Quarterly 2023-06-30 79616000.0 +54.4% USD 10-Q 2024-08-02
Quarterly 2023-09-30 -52253000.0 -165.6% USD 10-Q 2024-11-01
Quarterly 2024-03-31 -15335000.0 +70.7% USD 10-Q 2025-05-02
Quarterly 2024-06-30 38653000.0 +352.1% USD 10-Q 2025-08-01
Quarterly 2024-09-30 29097000.0 -24.7% USD 10-Q 2025-10-28
Quarterly 2025-03-31 50739000.0 +74.4% USD 10-Q 2025-05-02
Quarterly 2025-06-30 48557000.0 -4.3% USD 10-Q 2025-08-01
Quarterly 2025-09-30 87843000.0 +80.9% USD 10-Q 2025-10-28
Annual 2022-12-31 187830000.0 USD 10-K 2025-03-06
Annual 2023-12-31 58125000.0 -69.1% USD 10-K 2026-02-27
Annual 2024-12-31 107954000.0 +85.7% USD 10-K 2026-02-27
Annual 2025-12-31 295252000.0 +173.5% USD 10-K 2026-02-27

Net Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 -22276000.0 USD 10-Q 2024-05-02
Quarterly 2023-06-30 2766000.0 +112.4% USD 10-Q 2024-08-02
Quarterly 2023-09-30 -130124000.0 -4804.4% USD 10-Q 2024-11-01
Quarterly 2024-03-31 -46385000.0 +64.4% USD 10-Q 2025-05-02
Quarterly 2024-06-30 19441000.0 +141.9% USD 10-Q 2025-08-01
Quarterly 2024-09-30 -8981000.0 -146.2% USD 10-Q 2025-10-28
Quarterly 2025-03-31 29010000.0 +423.0% USD 10-Q 2025-05-02
Quarterly 2025-06-30 27542000.0 -5.1% USD 10-Q 2025-08-01
Quarterly 2025-09-30 55241000.0 +100.6% USD 10-Q 2025-10-28
Annual 2022-12-31 -54219000.0 USD 10-K 2025-03-06
Annual 2023-12-31 -156835000.0 -189.3% USD 10-K 2026-02-27
Annual 2024-12-31 -20521000.0 +86.9% USD 10-K 2026-02-27
Annual 2025-12-31 189113000.0 +1021.6% USD 10-K 2026-02-27

EPS Basic

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 -0.18 USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.03 +116.7% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 -1.11 -3800.0% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 -0.26 +76.6% USD/shares 10-Q 2025-05-02
Quarterly 2024-06-30 0.1 +138.5% USD/shares 10-Q 2025-08-01
Quarterly 2024-09-30 -0.04 -140.0% USD/shares 10-Q 2025-10-28
Quarterly 2025-03-31 0.15 +475.0% USD/shares 10-Q 2025-05-02
Quarterly 2025-06-30 0.14 -6.7% USD/shares 10-Q 2025-08-01
Quarterly 2025-09-30 0.27 +92.9% USD/shares 10-Q 2025-10-28
Annual 2022-12-31 -0.46 USD/shares 10-K 2025-03-06
Annual 2023-12-31 -1.31 -184.8% USD/shares 10-K 2026-02-27
Annual 2024-12-31 -0.09 +93.1% USD/shares 10-K 2026-02-27
Annual 2025-12-31 0.94 +1144.4% USD/shares 10-K 2026-02-27

EPS Diluted

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 -0.18 USD/shares 10-Q 2024-05-02
Quarterly 2023-06-30 0.03 +116.7% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 -1.11 -3800.0% USD/shares 10-Q 2024-11-01
Quarterly 2024-03-31 -0.26 +76.6% USD/shares 10-Q 2025-05-02
Quarterly 2024-06-30 0.1 +138.5% USD/shares 10-Q 2025-08-01
Quarterly 2024-09-30 -0.04 -140.0% USD/shares 10-Q 2025-10-28
Quarterly 2025-03-31 0.14 +450.0% USD/shares 10-Q 2025-05-02
Quarterly 2025-06-30 0.13 -7.1% USD/shares 10-Q 2025-08-01
Quarterly 2025-09-30 0.26 +100.0% USD/shares 10-Q 2025-10-28
Annual 2022-12-31 -0.46 USD/shares 10-K 2025-03-06
Annual 2023-12-31 -1.31 -184.8% USD/shares 10-K 2026-02-27
Annual 2024-12-31 -0.09 +93.1% USD/shares 10-K 2026-02-27
Annual 2025-12-31 0.87 +1066.7% USD/shares 10-K 2026-02-27

8-K Material Event Details

27 filings · 63 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

55 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-30 Barnes Robert Allen President, Community Living Other disposed transaction
F
Common Stock 6,748 $41.54 $280,312 25,549
2026-03-20 ROUSSEAU JON B See Remarks Equity grant / award
G · derivative
Stock Options (Right to Buy) 192,704 $0.00 $0 192,704
2026-03-20 ROUSSEAU JON B See Remarks Equity grant / award
G · derivative
Stock Options (Right to Buy) 180,753 $0.00 $0 180,753
2026-03-05 Nalley Lisa A See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 52,344 $0.00 $0 52,344
2026-03-05 Nalley Lisa A See Remarks Equity grant / award
A
Common Stock 21,354 $0.00 $0 131,948
2026-03-05 Greenwell Scott A. President, PharMerica Equity grant / award
A · derivative
Stock Options (Right to Buy) 49,073 $0.00 $0 49,073
2026-03-05 Greenwell Scott A. President, PharMerica Equity grant / award
A
Common Stock 20,020 $0.00 $0 36,859
2026-03-04 Nalley Lisa A See Remarks Exercise / conversion
M · derivative
Stock Options (Right to Buy) 30,000 $0.00 $0 76,909
2026-03-04 Nalley Lisa A See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 3,925 $0.00 $0 15,702
2026-03-04 Nalley Lisa A See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 35,331 $0.00 $0 106,909
2026-03-04 Nalley Lisa A See Remarks Open-market sell
S
Common Stock 30,000 $41.15 $1,234,500 110,594
2026-03-04 Nalley Lisa A See Remarks Exercise / conversion
M
Common Stock 30,000 $6.37 $191,100 140,594
2026-01-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 49,304 $39.64 $1,954,411 1,023,880
2025-11-05 Miller Steven B Other disposed transaction
F
Common Stock 4,497 $32.68 $146,962 18,123
2025-10-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 49,796 $33.53 $1,669,660 1,082,134
2025-10-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 58,746 $33.53 $1,969,753 1,073,184
2025-10-22 KKR Group Partnership L.P. Equity grant / award
G
Common Stock 39,493 $0.00 $0 0
2025-10-22 KKR Group Partnership L.P. Equity grant / award
G
Common Stock 50,484 $0.00 $0 0
2025-10-22 KKR Group Partnership L.P. Other disposed transaction
J
Common Stock 409,305 $0.00 $0 61,942,032
2025-10-22 KKR Group Partnership L.P. Open-market sell
S
Common Stock 14,745,000 $28.78 $424,390,590 62,351,337
2025-07-25 ROUSSEAU JON B See Remarks Other acquired transaction
F
Common Stock 52,203 $20.53 $1,071,728 1,131,930
2025-06-24 KKR Group Partnership L.P. Open-market sell
S
Common Stock 2,100,000 $21.15 $44,418,990 77,096,337
2025-06-20 Greenwell Scott A. President, PharMerica Equity grant / award
A · derivative
Stock Options (Right to Buy) 35,920 $0.00 $0 35,920
2025-06-20 Greenwell Scott A. President, PharMerica Equity grant / award
A
Common Stock 16,839 $0.00 $0 16,839
2025-06-12 KKR Group Partnership L.P. Equity grant / award
G
Common Stock 51,364 $0.00 $0 0
2025-06-12 KKR Group Partnership L.P. Equity grant / award
G
Common Stock 60,002 $0.00 $0 0
2025-06-12 KKR Group Partnership L.P. Other disposed transaction
J
Common Stock 475,546 $0.00 $0 79,196,337
2025-06-12 KKR Group Partnership L.P. Open-market sell
S
Common Stock 13,288,101 $21.15 $281,068,584 79,671,883
2025-05-05 Wicks Timothy A Equity grant / award
A
Common Stock 11,912 $0.00 $0 20,521
2025-05-03 Wicks Timothy A Other disposed transaction
F
Common Stock 7,044 $20.87 $147,008 8,609
2025-04-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 48,887 $16.55 $809,080 1,184,133
2025-03-17 ROUSSEAU JON B See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 733,496 $0.00 $0 733,496
2025-03-17 ROUSSEAU JON B See Remarks Equity grant / award
A
Common Stock 345,424 $0.00 $0 1,233,020
2025-02-18 Walgreens Boots Alliance, Inc. Open-market sell
S
Common Stock 12,000,000 $21.16 $253,920,000 11,239,996
2025-01-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 44,362 $22.82 $1,012,341 887,596
2024-11-05 Miller Steven B Equity grant / award
A
Common Stock 10,708 $0.00 $0 10,708
2024-10-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 36,740 $15.50 $569,470 931,958
2024-09-11 Walgreens Boots Alliance, Inc. Open-market sell
S
Common Stock 11,619,998 $129,330,577.74 $1,502,821,054,677,644 23,239,996
2024-07-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 20,198 $12.09 $244,194 968,698
2024-05-20 DAmbrosio Matthew Open-market buy
P
Common Stock 1,000 $11.46 $11,461 1,000
2024-05-10 KIRTLEY OLIVIA F Equity grant / award
A
Common Stock 4,449 $0.00 $0 20,102
2024-05-03 KIRTLEY OLIVIA F Equity grant / award
A
Common Stock 15,653 $0.00 $0 15,653
2024-04-25 ROUSSEAU JON B See Remarks Other disposed transaction
F
Common Stock 36,740 $10.41 $382,463 988,896
2024-03-15 Yowler Jennifer President, PharMerica Open-market buy
P
Common Stock 3,000 $8.21 $24,630 60,880
2024-03-14 Phipps Jennifer A Chief Accounting Officer Open-market buy
P
Common Stock 12,300 $8.14 $100,122 165,618
2024-03-14 ROUSSEAU JON B See Remarks Open-market buy
P
Common Stock 37,405 $8.12 $303,729 1,007,236
2024-01-26 ROUSSEAU JON B See Remarks Equity grant / award
A
Common Stock 967,884 $0.00 $0 969,831
2024-01-26 McMaude Michael A See Remarks Equity grant / award
A
Common Stock 51,442 $0.00 $0 334,090
2024-01-25 ROUSSEAU JON B See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 320,086 $0.00 $0 320,086
2024-01-25 ROUSSEAU JON B See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 955,823 $0.00 $0 1,327,081
2024-01-25 McMaude Michael A See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 18,670 $0.00 $0 18,670
2024-01-25 McMaude Michael A See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 33,349 $0.00 $0 103,048
2023-11-22 ROUSSEAU JON B See Remarks Equity grant / award
A · derivative
Stock Options (Right to Buy) 628,108 $0.00 $0 628,108
2023-11-21 ROUSSEAU JON B See Remarks Other disposed transaction
D · derivative
Stock Options (Right to Buy) 412,195 $15.92 $6,562,144 534,676
2023-11-21 ROUSSEAU JON B See Remarks Other disposed transaction
D · derivative
Stock Options (Right to Buy) 215,912 $15.92 $3,437,319 371,258

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
17
Material Event Filings (8-K) — 12 months
10

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.